Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BAYGN | Derived | EUR | Real-time | |
BAYGn | Xetra | EUR | Delayed | |
BAYNd | BATS Europe | EUR | Delayed | |
BAYRY | OTC Markets | USD | Delayed | |
0P6S | London | EUR | Real-time | |
BAYNN | BIVA | MXN | Delayed | |
BAYNN | Mexico | MXN | Delayed | |
BAYG | Milan | EUR | Real-time | |
BAYGn | Dusseldorf | EUR | Delayed | |
BAYGn | Hamburg | EUR | Delayed | |
BAYGn | TradeGate | EUR | Delayed | |
BAYGn | Frankfurt | EUR | Delayed | |
BAY1 | Warsaw | PLN | Delayed | |
BAYGn | Vienna | EUR | Real-time | |
BAYG | Budapest | HUF | Delayed | |
BAYN | Bucharest | RON | Delayed |
Bayer AG (ETR:BAYGN)'s CEO, Bill Anderson, is contemplating a significant restructuring of the pharma-agriculture conglomerate, potentially dismantling the legacy of his...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Neutral | Neutral | Sell | Strong Sell |
Technical Indicators | BUY | BUY | Sell | Neutral | Strong Sell |
Summary | Neutral | Neutral | Neutral | Neutral | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Inverted Hammer | 1H | Current | |||
Falling Three Methods | 5H | Current | |||
Completed Patterns | |||||
Three Outside Up | 1D | 2 | Apr 22, 2024 | ||
Bullish Engulfing | 1D | 3 | Apr 19, 2024 | ||
Dragonfly Doji | 30 | 3 | Apr 24, 2024 10:00 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Real-time derived | 27.21 | - | - | - | -0.51% | EUR | |||
Xetra | 27.21 | 27.19 | 27.20 | 681,487 | -0.51% | EUR | |||
BATS Europe | 27.16 | 0.00 | 0.00 | 0 | 0.00% | EUR | |||
OTC Markets | 7.38 | 0.00 | 0.00 | 1,742,069 | +0.34% | USD | |||
London | 27.19 | 26.89 | 27.44 | 49,855 | -0.29% | EUR | |||
BIVA | 940.92 | 0.00 | 0.00 | 0 | 0.00% | MXN | |||
Mexico | 541.80 | 542.00 | 649.00 | 0 | 0.00% | MXN | |||
Milan | 27.20 | 0.00 | 0.00 | 13,583 | -0.38% | EUR | |||
Dusseldorf | 27.22 | 27.19 | 27.20 | 5 | -0.29% | EUR | |||
Hamburg | 27.22 | 27.19 | 27.20 | 138 | -0.06% | EUR | |||
TradeGate | 27.20 | 27.19 | 27.20 | 87,207 | -0.87% | EUR | |||
Frankfurt | 27.20 | 27.19 | 27.20 | 1,722 | +0.74% | EUR | |||
Warsaw | 118.40 | 116.18 | 118.40 | 0 | 0.00% | PLN | |||
Vienna | 25.95 | 25.95 | 26.24 | 0 | 0.00% | EUR | |||
Budapest | 10,716.00 | 10,672.00 | 10,714.00 | 0 | 0.00% | HUF | |||
Bucharest | 137.9800 | 363.5000 | 368.8500 | 16 | +0.72% | RON |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Lloyds Banking | 52.54 | 52.80 | 49.62 | +1.20 | +2.34% | 111.11M | |||
Rolls-Royce Holdings | 417.80 | 424.20 | 416.60 | +0.60 | +0.14% | 4.63M | 12:08:44 | ||
IAG | 176.18 | 178.45 | 175.60 | +0.23 | +0.13% | 4.91M | |||
Barclays | 192.62 | 193.44 | 190.66 | +0.38 | +0.20% | 13.99M | 12:08:48 | ||
HSBC | 666.40 | 668.40 | 664.00 | -1.30 | -0.19% | 5.21M | |||
BP | 529.20 | 531.40 | 528.20 | +6.10 | +1.17% | 6.12M | |||
Vodafone Group PLC | 70.016 | 70.016 | 68.878 | +0.396 | +0.57% | 13.19M | |||
British American Tobacco | 2,375.0 | 2,378.0 | 2,353.0 | +15.0 | +0.64% | 1.02M | |||
Legal & General | 253.64 | 254.20 | 251.00 | +0.54 | +0.21% | 8.95M | |||
BAE Systems | 1,376.95 | 1,378.50 | 1,345.00 | +36.95 | +2.76% | 2.71M |
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review